[HTML][HTML] Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations–A review

M Kumar, AR Hilles, SH Almurisi, A Bhatia, S Mahmood - JCIS Open, 2023 - Elsevier
The lung is an attractive target for drug delivery because of the ease of non-invasive
administration via inhalation, bypassing metabolism in the liver, direct delivery to the …

Dendrimer toxicity: Let's meet the challenge

K Jain, P Kesharwani, U Gupta, NK Jain - International journal of …, 2010 - Elsevier
Dendrimers are well-defined, versatile polymeric architecture with properties resembling
biomolecules. Dendritic polymers emerged as outstanding carrier in modern medicine …

Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases

F Andrade, D Rafael, M Videira, D Ferreira… - Advanced drug delivery …, 2013 - Elsevier
Used since ancient times especially for the local treatment of pulmonary diseases, lungs and
airways are a versatile target route for the administration of both local and systemic drugs …

Colloidal drug carriers: achievements and perspectives

G Barratt - Cellular and Molecular Life Sciences CMLS, 2003 - Springer
Colloidal drug carriers such as liposomes and nanoparticles are able to modify the
distribution of an associated substance. They can therefore be used to improve the …

Delivery systems to increase the selectivity of antibiotics in phagocytic cells

E Briones, CI Colino, JM Lanao - Journal of Controlled Release, 2008 - Elsevier
Many infectious diseases are caused by facultative organisms that are able to survive in
phagocytic cells. The intracellular location of these microorganisms protects them from the …

[HTML][HTML] Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis–A review

P Prasanna, P Kumar, S Kumar, VK Rajana… - Biomedicine & …, 2021 - Elsevier
The study of tropical diseases like leishmaniasis, a parasitic disease, has not received much
attention even though it is the second-largest infectious disease after malaria. As per the …

Nanostructured delivery systems with improved leishmanicidal activity: a critical review

N Bruni, B Stella, L Giraudo, C Della Pepa… - International journal …, 2017 - Taylor & Francis
Leishmaniasis is a vector-borne zoonotic disease caused by protozoan parasites of the
genus Leishmania, which are responsible for numerous clinical manifestations, such as …

New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment

MA Chávez-Fumagalli, TG Ribeiro… - Revista da Sociedade …, 2015 - SciELO Brasil
Leishmaniasis is one of the six major tropical diseases targeted by the World Health
Organization. It is a life-threatening disease of medical, social and economic importance in …

Characterization and evaluation of amphotericin B loaded MDP conjugated poly (propylene imine) dendrimers

K Jain, AK Verma, PR Mishra, NK Jain - … : Nanotechnology, Biology and …, 2015 - Elsevier
This paper describes a novel strategy for targeted delivery of amphotericin B (AmB) to
macrophages with muramyl dipeptide (MDP) conjugated multimeric poly …

Surface-Engineered Dendrimeric Nanoconjugates for Macrophage-Targeted Delivery of Amphotericin B: Formulation Development and In Vitro and In Vivo …

K Jain, AK Verma, PR Mishra… - Antimicrobial agents and …, 2015 - Am Soc Microbiol
The present study aimed to develop an optimized dendrimeric delivery system for
amphotericin B (AmB). Fifth-generation (5.0 G) poly (propylene imine)(PPI) dendrimers were …